The world should be back to normal by the end of 2022 thanks to Covid-19 vaccines, Bill Gates said in an interview for Polish newspaper Gazeta Wyborcza and television broadcaster TVN24.
The World Health Organization-backed COVAX vaccine sharing facility has an agreement to send out “hundreds of millions” of Johnson & Johnson shots, Kate O’Brien – director of WHO’s department of immunization – said on March 17.
COVAX will deliver 237 million doses of AstraZeneca’s Covid-19 shot to 142 countries by the end of May as the World Health Organization-backed program steps up the global roll-out of its vaccine supplies.
Many health experts believe that the Covid-19 vaccine candidate NVX-CoV237 from Novavax offers potential advantages over competitors including Pfizer-BioNTech, Moderna, Johnson & Johnson, and AstraZeneca-Oxford.
Novavax announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance, to provide 1.1 billion doses of the company’s Covid-19 vaccine candidate NVX-CoV2373 for the COVAX Facility.
The United States under President Joe Biden intends to join the COVAX vaccine facility that aims to deliver coronavirus vaccines to poor countries, his chief medical adviser, Anthony Fauci, told the World Health Organization (WHO).
French drugmaker Sanofi and Britain’s GlaxoSmithKline will supply 200 million doses of their Covid-19 candidate vaccine to a global inoculation scheme backed by the World Health Organization.
Some 172 countries are engaging with the COVAX facility designed to ensure equitable access to Covid-19 vaccines, the World Health Organization said, but more funding is needed and countries need now to make binding commitments.
Coordinators of a global coronavirus vaccines funding scheme are looking at a wide range of potential prices for Covid-19 shots, with a reported $40 per dose price tag the “highest number” in that range, one of the co-leads of the project said.
More than 75 countries expressed interest in joining the COVAX financing scheme designed to guarantee fast and equitable access globally to Covid-19 vaccines, the GAVI vaccines alliance said,
